10 results on '"Brouwers, Adrienne H."'
Search Results
2. Progressive diastolic dysfunction in survivors of pediatric differentiated thyroid carcinoma.
- Author
-
Reichert, Antoinette D., Nies, Marloes, Tissing, Wim J. E., Kobold, Anneke C. Muller, Hesselink, Mariëlle S. Klein, Brouwers, Adrienne H., Havekes, Bas, van den Heuvel-Eibrink, Marry M., van der Pal, Helena J. H., Plukker, John T. M., van Santen, Hanneke M., Corssmit, Eleonora P. M., Netea-Maier, Romana T., Peeters, Robin P., van Dam, Eveline W. C. M., Burgerhof, Johannes G. M., van der Meer, Peter, Bocca, Gianni, and Links, Thera P.
- Subjects
THYROID cancer ,VENTRICULAR ejection fraction ,ECHOCARDIOGRAPHY - Abstract
Background: Pediatric differentiated thyroid cancer (DTC) has an excellent prognosis but unknown late effects of treatment. The initial cardiac evaluation showed subclinical di astolic dysfunction in 20% of adult survivors. The objective of this follow-up study was to determine the clinical course of this finding. Methods: This multicenter study, conducted between 2018 and 2020, re-evaluated survivors after 5 years. The primary endpoint was echocardiographic diastolic cardiac function (depicted by the mean of the early diastolic septal and early diastolic lateral tissue velocity (e' mean)). Secondary endpoints were other echocardiographic parameters and plasma biomarkers. Results: Follow-up evaluation was completed in 47 (71.2%) of 66 survivo rs who had completed their initial evaluation. Of these 47 survivors, 87.2% were women. The median age was 39. 8 years (range: 18.8-60.3), and the median follow-up after the initial diagnosis was 23.4 years (range: 10 .2-48.8). Between the first and second evaluation, the e' mean significantly decreased by 2.1 cm/s (s.d. 2.3 cm/s, P < 0.001). The median left ventricular ejection fraction did not significantly change (58.0% vs 59.0%, P= NS). In the best explanatory model of e' mean, multivariate linea r regression analysis showed that BMI and age were significantly associated w ith e' mean (ß coefficient: -0.169, 95% CI: -0.292; -0.047, P = 0.008 and ß coefficient: -0.177, 95% CI: -0.240; -0.113, P < 0.001, respectively). Conclusions and relevance: In these relatively young survivors of pediatric DTC, diastoli c function decreased significantly during 5-year follow-up and is possibly more pronounced than in normal aging. This finding requires further follow-up to assess clinical consequences. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial.
- Author
-
de Koster, Elizabeth J., de Geus-Oei, Lioe-Fee, Brouwers, Adrienne H., van Dam, Eveline W. C. M., Dijkhorst-Oei, Lioe-Ting, van Engen-van Grunsven, Adriana C. H., van den Hout, Wilbert B., Klooker, Tamira K., Netea-Maier, Romana T., Snel, Marieke, Oyen, Wim J. G., and Vriens, Dennis
- Subjects
THYROID cancer ,THYROID gland surgery ,EMISSION-computed tomography ,NODULAR disease ,TUMORS - Abstract
Purpose: To assess the impact of an [
18 F]FDG-PET/CT-driven diagnostic workup to rule out malignancy, avoid futile diagnostic surgeries, and improve patient outcomes in thyroid nodules with indeterminate cytology. Methods: In this double-blinded, randomised controlled multicentre trial, 132 adult euthyroid patients with scheduled diagnostic surgery for a Bethesda III or IV thyroid nodule underwent [18 F]FDG-PET/CT and were randomised to an [18 F]FDG-PET/CT-driven or diagnostic surgery group. In the [18 F]FDG-PET/CT-driven group, management was based on the [18 F]FDG-PET/CT result: when the index nodule was visually [18 F]FDG-positive, diagnostic surgery was advised; when [18 F]FDG-negative, active surveillance was recommended. The nodule was presumed benign when it remained unchanged on ultrasound surveillance. In the diagnostic surgery group, all patients were advised to proceed to the scheduled surgery, according to current guidelines. The primary outcome was the fraction of unbeneficial patient management in one year, i.e., diagnostic surgery for benign nodules and active surveillance for malignant/borderline nodules. Intention-to-treat analysis was performed. Subgroup analyses were performed for non-Hürthle cell and Hürthle cell nodules. Results: Patient management was unbeneficial in 42% (38/91 [95% confidence interval [CI], 32–53%]) of patients in the [18 F]FDG-PET/CT-driven group, as compared to 83% (34/41 [95% CI, 68–93%]) in the diagnostic surgery group (p < 0.001). [18 F]FDG-PET/CT-driven management avoided 40% (25/63 [95% CI, 28–53%]) diagnostic surgeries for benign nodules: 48% (23/48 [95% CI, 33–63%]) in non-Hürthle cell and 13% (2/15 [95% CI, 2–40%]) in Hürthle cell nodules (p = 0.02). No malignant or borderline tumours were observed in patients under surveillance. Sensitivity, specificity, negative and positive predictive value, and benign call rate (95% CI) of [18 F]FDG-PET/CT were 94.1% (80.3–99.3%), 39.8% (30.0–50.2%), 95.1% (83.5–99.4%), 35.2% (25.4–45.9%), and 31.1% (23.3–39.7%), respectively. Conclusion: An [18 F]FDG-PET/CT-driven diagnostic workup of indeterminate thyroid nodules leads to practice changing management, accurately and oncologically safely reducing futile surgeries by 40%. For optimal therapeutic yield, application should be limited to non-Hürthle cell nodules. Trial registration number: This trial is registered with ClinicalTrials.gov: NCT02208544 (5 August 2014), https://clinicaltrials.gov/ct2/show/NCT02208544. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
4. Bone Mineral Density in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma: A Longitudinal Follow-Up Study.
- Author
-
Dekker, Bernadette L., Muller Kobold, Anneke C., Brouwers, Adrienne H., Williams, Graham R., Nies, Marloes, Klein Hesselink, Mariëlle S., van der Horst-Schrivers, Anouk N.A., Havekes, Bas, van den Heuvel-Eibrink, Marry M., van der Pal, Heleen J.H., Plukker, John Th. M., Ronckers, Cecile M., van Santen, Hanneke M., Burgerhof, Johannes G.M., Corssmit, Eleonora P.M., Netea-Maier, Romana T., Peeters, Robin P., van Dam, Eveline W.C.M., Boot, Annemieke M., and Tissing, Wim J.E.
- Subjects
BONE density ,OSTEOPOROSIS ,THYROID cancer ,DUAL-energy X-ray absorptiometry ,LONGITUDINAL method ,LUMBAR vertebrae - Abstract
Background: Survivors of pediatric differentiated thyroid carcinoma (DTC) receive thyrotropin-suppressive therapy to minimize disease recurrence. However, knowledge about long-term effects of subclinical hyperthyroidism on bone mineral density (BMD) in pediatric DTC survivors is scarce, as is the information regarding long-term consequences of permanent hypoparathyroidism on BMD. We evaluated BMD in pediatric DTC survivors and investigated if BMD was affected by subclinical hyperthyroidism and/or permanent hypoparathyroidism during long-term follow-up. Methods: In this nationwide longitudinal study, we determined BMD in the lumbar spine and femur by dual energy X-ray absorptiometry in 65 pediatric DTC survivors. Measurements were repeated after minimal 5 years of follow-up in 46 pediatric DTC survivors. BMD results were evaluated according to the recommendations of the International Society for Clinical Densitometry (ISCD) and WHO. At both visits, we determined biochemical parameters and markers of bone resorption (C-terminal telopeptide of type I collagen [β-CTX]) and formation (N-propeptide of type I collagen [PINP] and osteocalcin). Results: First and second BMD measurements were done after a median follow-up of 17.0 (interquartile range [IQR] 8.0–25.0) and 23.5 (IQR 14.0–30.0) years after diagnosis, respectively. Median age at diagnosis was 15 years (IQR 13.0–17.0). Twenty-nine percent of the survivors had subclinical hyperthyroidism. In most survivors, BMD T- and Z-scores were within the reference range during both BMD evaluations. However, after 23.5 years of follow-up, a low BMD was found in 13.0%. In the 13 survivors with permanent hypoparathyroidism, BMD values did not differ after 5 years of follow-up compared with baseline values or in comparison with the 33 survivors without permanent hypoparathyroidism. During follow-up, turnover markers β-CTX and PINP remained stable. Conclusions: This longitudinal study of pediatric DTC survivors demonstrated normal and stable median lumbar spine and femur BMD values after a median time of 17 and 23.5 years after diagnosis. However, compared with controls, a lower BMD was still found in 13.0% after prolonged follow-up despite intensive follow-up. Based on the studied follow-up period, these data do not provide convincing evidence in support of standard monitoring of bone mass among DTC survivors, but may be restricted to individual cases at low frequency. Trial Registration: This follow-up study was registered in The Netherlands Trial Register under no. NL3280 (www.trialregister.nl/trial/3280). [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. The Value of Pre-Ablative I-131 Scan for Clinical Management in Patients With Differentiated Thyroid Carcinoma.
- Author
-
van der Boom, Trynke, Zandee, Wouter T., Dekkers, Claire C. J., van der Horst-Schrivers, Anouk N. A., Jansen, Liesbeth, Kruijff, Schelto, Brouwers, Adrienne H., and Links, Thera P.
- Subjects
WHOLE body imaging ,THYROID cancer ,LOGISTIC regression analysis - Abstract
Background: A diagnostic I-131 (Dx) scan is used to detect a thyroid remnant or metastases before treatment of differentiated thyroid cancer (DTC) with I-131. The aim of this study is to specify in which patients with DTC a Dx scan could have an additional value, by studying the effect of the Dx scan on clinical management. Methods: Patients with DTC, treated with I-131 after thyroidectomy were included in this retrospective cohort study. Twenty-four hours after administration of 37 MBq I-131 a whole body Dx scan and an uptake measurement at the original thyroid bed were performed. Outcomes of the Dx scan and the subsequent changes in clinical management, defined as additional surgery or adjustment of I-131 activity, were reported. Risk factors for a change in clinical management were identified with a binary logistic regression. Results: In 11 (4.2%) patients clinical management was changed, including additional surgery (n=5), lowering I-131 activity (n=5) or both (n=1). Risk factors for a change in clinical management were previous neck surgery (OR 5.9, 95% CI: 1.4-24.5), surgery in a non-tertiary center (OR 13.4, 95% CI: 2.8 – 63.8), TSH <53.4 mU/L (OR 19.64, 95% CI: 4.94-78.13), thyroglobulin ≥50.0 ng/L (OR 7.4, 95% CI: 1.6-34.9) and free T4 ≥4.75 pmol/L (OR 156.8, 95% CI: 128.4-864.2) Conclusion: The Dx scan can potentially change clinical management before treatment with I-131, but the yield is low. A Dx-scan should only be considered for patients with a high pre-scan risk of a change in management, based on patient history and prior center-based surgical outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
- Author
-
Nies, Marloes, Cantineau, Astrid E.P., Arts, Eus G.J.M., van den Berg, Marleen H., van Leeuwen, Flora E., Muller Kobold, Anneke C., Klein Hesselink, Mariëlle S., Burgerhof, Johannes G.M., Brouwers, Adrienne H., van Dam, Eveline W.C.M., Havekes, Bas, van den Heuvel-Eibrink, Marry M., Corssmit, Eleonora P.M., Kremer, Leontien C.M., Netea-Maier, Romana T., van der Pal, Helena J.H., Peeters, Robin P., Plukker, John T.M., Ronckers, Cécile M., and van Santen, Hanneke M.
- Subjects
THYROID cancer ,TREATMENT effectiveness ,PREMATURE menopause ,FERTILITY ,ANTI-Mullerian hormone ,OVARIAN reserve - Abstract
Background: Differentiated thyroid carcinoma (DTC) during childhood is a rare disease. Its excellent survival rate requires a focus on possible long-term adverse effects. This study aimed to evaluate fertility in female survivors of childhood DTC by assessing various reproductive characteristics combined with anti-Müllerian hormone (AMH) levels (a marker of ovarian reserve). Methods: Female survivors of childhood DTC, diagnosed at ≤18 years of age between 1970 and 2013, were included. Survivors were excluded when follow-up time was less than five years or if they developed other malignancies before or after diagnosis of DTC. Survivors filled out a questionnaire regarding reproductive characteristics (e.g., age at menarche and menopause, pregnancies, pregnancy outcomes, need for assisted reproductive therapy). Survivors aged <18 years during evaluation received an altered questionnaire without questions regarding pregnancy and pregnancy outcomes. These data were combined with information from medical records. AMH levels were measured in serum samples and were compared with AMH levels from 420 women not treated for cancer. Results: Fifty-six survivors with a median age of 31.0 (interquartile range, IQR, 25.1–39.6) years were evaluated after a median follow-up of 15.4 (IQR 8.3–24.7) years. The median cumulative dose of
131 I administered was 7.4 (IQR 3.7–13.0) GBq/200.0 (IQR 100.0–350.0) mCi. Twenty-five of the 55 survivors aged 18 years or older during evaluation reported 64 pregnancies, 45 of which resulted in live birth. Of these 55, 10.9% visited a fertility clinic. None of the survivors reported premature menopause. Age at AMH evaluation did not differ between DTC survivors and the comparison group (p = 0.268). Median AMH levels did not differ between DTC survivors and the comparison group [2.0 (IQR 1.0–3.7) μg/L vs. 1.6 (IQR 0.6–3.1) μg/L, respectively, p = 0.244]. The cumulative dose of131 I was not associated with AMH levels in DTC survivors (rs = 0.210, p = 0.130). Conclusions: Female survivors of DTC who received131 I treatment during childhood do not appear to have major abnormalities in reproductive characteristics nor in predictors of ovarian failure. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
7. Psychosocial development in survivors of childhood differentiated thyroid carcinoma: a cross-sectional study.
- Author
-
Nies, Marloes, Dekker, Bernadette L., Sulkers, Esther, Huizinga, Gea A., Hesselink, Mariëlle S. Klein, Maurice-Stam, Heleen, Grootenhuis, Martha A., Brouwers, Adrienne H., Burgerhof, Johannes G. M., van Dam, Eveline W. C. M., Havekes, Bas, van den Heuvel-Eibrink, Marry M., Corssmit, Eleonora P. M., Kremer, Leontien C. M., Netea-Maier, Romana T., Hv an der Pal, Heleen J., Peeters, Robin P., Plukker, John T. M., Ronckers, Cécile M., and van Santen, Hanneke M.
- Subjects
PSYCHOSOCIAL development theory ,THYROID cancer ,CHILDHOOD cancer - Abstract
Objective: The impact of childhood differentiated thyroid carcinoma (DTC) on psychosocial development has not yet been studied. The aim of this study was to evaluate the achievement of psychosocial developmental milestones in long-term survivors of childhood DTC. Design and methods: Survivors of childhood DTC diagnosed between 1970 and 2013 were included. Reasons for exclusion were age <18 or >35 years at follow-up, a follow-up period <5 years or diagnosis with DTC as a second malignant neoplasm. Survivors gathered peer controls of similar age and sex (n = 30). A comparison group non-affected with cancer (n = 508) and other childhood cancer survivors (CCS) were also used to compare psychosocial development. To assess the achievement of psychosocial milestones (social, autonomy and psychosexual development), the course of life questionnaire (CoLQ) was used. Results: We included 39 survivors of childhood DTC (response rate 83.0%, mean age at diagnosis 15.6 years, and mean age at evaluation 26.1 years). CoLQ scores did not significantly differ between survivors of childhood DTC and the two non-affected groups. CoLQ scores of childhood DTC survivors were compared to scores of other CCS diagnosed at similar ages (n = 76). DTC survivors scored significantly higher on social development than other CCS, but scores were similar on autonomy and psychosexual developmental scales. Conclusions: Survivors of childhood DTC showed similar development on social, autonomy, and psychosexual domains compared to non-affected individuals. Social development was slightly more favorable in DTC survivors than in other CCS, but was similar on autonomy and psychosexual domains. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
8. Diastolic Dysfunction is Common in Survivors of Pediatric Differentiated Thyroid Carcinoma.
- Author
-
Klein Hesselink, Mariëlle S., Bocca, Gianni, Hummel, Yoran M., Brouwers, Adrienne H., Burgerhof, Johannes G.M., van Dam, Eveline W.C.M., Gietema, Jourik A., Havekes, Bas, van den Heuvel-Eibrink, Marry M., Corssmit, Eleonora P.M., Kremer, Leontien C.M., Netea-Maier, Romana T., van der Pal, Helena J.H., Peeters, Robin P., Plukker, John T.M., Ronckers, Cécile M., van Santen, Hanneke M., van der Meer, Peter, Links, Thera P., and Tissing, Wim J.E.
- Subjects
THYROID cancer ,HEART disease risk factors ,ATRIAL fibrillation ,BIOMARKERS ,ECHOCARDIOGRAPHY - Abstract
Introduction: Whether pediatric patients with differentiated thyroid carcinoma (DTC) are at risk of developing treatment-related adverse effects on cardiac function is unknown. We therefore studied in long-term survivors of pediatric DTC the prevalence of cardiac dysfunction and atrial fibrillation in relation to treatment variables, and the association between cardiac dysfunction and plasma biomarkers. Methods: In this nationwide prospective multicenter study, cardiac assessments were performed in 66 adult survivors of pediatric DTC (age at diagnosis ≤18 years and follow-up ≥5 years after diagnosis) treated in the Netherlands between 1970 and 2009. Assessment included echocardiography, plasma biomarkers (N-terminal pro-brain natriuretic peptide, high-sensitive troponin-T, galectin-3), and 24-hour Holter electrocardiography. Echocardiographic measurements were compared with retrospective data of 66 sex- and age-matched unaffected Dutch controls. Diastolic dysfunction was defined as an early diastolic septal and/or lateral tissue velocity (e′) less than 2 SD of mean age-adjusted reference data. Results: The survivors (86.4% women) had at DTC diagnosis a median age of 16 years. Median follow-up was 17 years. Left ventricular ejection fraction <50% was found in one survivor, and median global longitudinal systolic strain was near normal. Diastolic dysfunction was present in 14 asymptomatic survivors (21.2%). Overall, diastolic function of survivors was lower compared with controls (e′mean 14.5 versus 15.8 cm/s, P = 0.006). Older attained age and higher waist circumference were associated with decreased diastolic function, whereas thyrotropin levels and cumulative administered radioiodine dose were not. In survivors, biomarkers were not associated with diastolic dysfunction; atrial fibrillation was not observed. Conclusion: While systolic function is unaffected, diastolic dysfunction is frequently observed in asymptomatic long-term survivors of pediatric DTC, which may suggest early cardiac aging. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
9. Optimization of parathyroid 11C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism.
- Author
-
Noltes, Milou E., Kruijff, Schelto, Noordzij, Walter, Telenga, Eef D., Vállez García, David, Trofimiuk-Müldner, Malgorzata, Opalińska, Marta, Hubalewska-Dydejczyk, Alicja, Luurtsema, Gert, Dierckx, Rudi A. J. O., El Moumni, Mostafa, Boellaard, Ronald, and Brouwers, Adrienne H.
- Subjects
ADENOMATOUS polyps ,POSITRON emission tomography ,THYROID cancer ,RADIOACTIVITY ,COMPUTED tomography - Abstract
Purpose: To evaluate the optimal tracer uptake time, the minimal amount of radioactivity and the inter-observer agreement for
11 C-choline positron emission tomography/computed tomography (PET/CT) in patients with primary hyperparathyroidism (pHPT). Methods: Twenty-one patients with biochemically proven pHPT were retrospectively studied after injection of 6.3 ± 1.2 MBq/kg11 C-choline. PET data of the first nine patients, scanned for up to 60 min, were reconstructed in 10-min frames from 10- to 60-min postinjection (p.i.), mimicking varying11 C-choline uptake times. Parathyroid adenoma to background contrast ratios were calculated and compared, using standardized uptake values (SUVs). Data was reconstructed with varying scan durations (1, 2.5, 5, and 10 min) at 20–30-min p.i. (established optimal uptake time), mimicking less administered radioactivity. To establish the minimal required radioactivity, the SUVs in the shorter scan durations (1, 2.5, and 5 min) were compared to the 10-min scan duration to determine whether increased variability and/or statistical differences were observed. Four observers analyzed the11 C-choline PET/CT in four randomized rounds for all patients. Results: SUVpeak of the adenoma decreased from 30 to 40 p.i. onwards. All adenoma/background contrast ratios did not differ from 20- to 30-min p.i. onwards. The SUVs of adenoma in the scan duration of 1, 2.5, and 5 min all differed significantly from the same SUV in the 10-min scan duration (all p = 0.012). However, the difference in absolute SUV adenoma values was well below 10% and therefore not considered clinically significant. The inter-observer analysis showed that the Fleiss' kappa of the 1-min scan were classified as "moderate," while these values were classified as "good" in the 2.5-, 5-, and 10-min scan duration. Observers scored lower certainty scores in the 1- and 2.5-min scans compared to the 5- and 10-min scan durations. Conclusion: The optimal time to start PET/CT scanning in patients with pHPT is 20 min after mean injection of 6.3 MBq/kg11 C-choline, with a recommended scan duration of at least 5 min. Alternatively, the radioactivity dose can be lowered by 50% while keeping a 10-min scan duration without losing the accuracy of11 C-choline PET/CT interpretation. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
10. NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk.
- Author
-
Klein Hesselink, Esther N., van der Horst-Schrivers, Anouk N.A., van der Horst, Iwan C.C., Bakker, Stephan J.L., Muller Kobold, Anneke C., Brouwers, Adrienne H., de Bock, Geertruida H., Gietema, Jourik A., Dullaart, Robin P.F., Links, Thera P., and Lefrandt, Joop D.
- Subjects
- *
THYROID cancer , *CARDIOVASCULAR diseases risk factors , *NATRIURETIC peptides , *REGRESSION analysis , *MORTALITY prevention , *CANCER risk factors , *THERAPEUTICS - Abstract
Introduction Chronic suppression of TSH in patients treated for differentiated thyroid carcinoma (DTC) may induce cardiac damage and increase risk for cardiovascular events and premature mortality. We aimed to compare circulating concentrations of N-terminal pro Brain Natriuretic Peptide (NT-proBNP) of DTC patients with controls, and to investigate whether higher NT-proBNP is associated with an increased risk for cardiovascular events and all-cause mortality in DTC patients. Methods Serum NT-proBNP levels were determined in 266 DTC patients, median 10.4 [IQR 4.1–18.5] years after DTC diagnosis, and compared to 798 age- and sex-matched controls. Using multivariable Cox regression analyses, the association of NT-proBNP with cardiovascular events and all-cause mortality was determined. Hazard ratios (HR) and 95% confidence intervals (CIs) were expressed per SD increase of log-transformed NT-proBNP. Results Mean age ± SD of DTC patients and controls was 54.8 ± 14.5 and 54.8 ± 12.8 years, respectively; 74% were women. Median NT-proBNP level was 70 [40–119] ng/L for DTC patients vs. 49 [25–89] ng/L for controls ( p < 0.001). During median follow-up of 8.6 [6.6–9.0] years, 30 DTC patients (11.4%) had a cardiovascular event and 38 (14.4%) died. Higher NT-proBNP was associated with an increased risk for cardiovascular events and all-cause mortality, age- and sex-adjusted HRs (95% CIs) 3.22 (2.17–4.79) and 1.61 (1.17–2.23), respectively. In further models with adjustment for cardiovascular risk factors, NT-proBNP remained independently associated with outcome. Conclusion NT-proBNP levels are elevated in patients with DTC, and are associated with an increased risk for cardiovascular events and all-cause mortality. Determination of NT-proBNP may identify DTC patients at increased cardiovascular risk, who could benefit from more stringent cardiovascular risk surveillance. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.